Combined Transplantation of Human MSCs and ECFCs Improves Cardiac Function and Decrease Cardiomyocyte Apoptosis after Acute Myocardial Infarction

Scientists examined the combination therapy of human mesenchymal stromal cells (MSCs) and endothelial colony-forming cells (ECFCs) to reduce the early ischemic damage and enhance angiogenesis in a pre-clinical model of acute myocardial infarction.